264 related articles for article (PubMed ID: 28935672)
1. The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain.
Bosnakovski D; Toso EA; Hartweck LM; Magli A; Lee HA; Thompson ER; Dandapat A; Perlingeiro RCR; Kyba M
J Cell Sci; 2017 Nov; 130(21):3685-3697. PubMed ID: 28935672
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
Haynes P; Kernan K; Zhou SL; Miller DG
Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
[TBL] [Abstract][Full Text] [Related]
3. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies.
Bosnakovski D; Xu Z; Gang EJ; Galindo CL; Liu M; Simsek T; Garner HR; Agha-Mohammadi S; Tassin A; Coppée F; Belayew A; Perlingeiro RR; Kyba M
EMBO J; 2008 Oct; 27(20):2766-79. PubMed ID: 18833193
[TBL] [Abstract][Full Text] [Related]
4. Pitx2c modulates Pax3+/Pax7+ cell populations and regulates Pax3 expression by repressing miR27 expression during myogenesis.
Lozano-Velasco E; Contreras A; Crist C; Hernández-Torres F; Franco D; Aránega AE
Dev Biol; 2011 Sep; 357(1):165-78. PubMed ID: 21749861
[TBL] [Abstract][Full Text] [Related]
5. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle.
Banerji CRS; Panamarova M; Hebaishi H; White RB; Relaix F; Severini S; Zammit PS
Nat Commun; 2017 Dec; 8(1):2152. PubMed ID: 29255294
[TBL] [Abstract][Full Text] [Related]
6. MyoD Over-Expression Rescues GST-bFGF Repressed Myogenesis.
Fan SH; Li N; Huang KF; Chang YT; Wu CC; Chen SL
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673893
[TBL] [Abstract][Full Text] [Related]
7. Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells.
Calhabeu F; Hayashi S; Morgan JE; Relaix F; Zammit PS
Oncogene; 2013 Jan; 32(5):651-62. PubMed ID: 22710712
[TBL] [Abstract][Full Text] [Related]
8. Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression.
Bosnakovski D; Gearhart MD; Toso EA; Ener ET; Choi SH; Kyba M
Sci Rep; 2018 Nov; 8(1):16957. PubMed ID: 30446688
[TBL] [Abstract][Full Text] [Related]
9. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
Banerji CRS; Zammit PS
EMBO Mol Med; 2021 Aug; 13(8):e13695. PubMed ID: 34151531
[TBL] [Abstract][Full Text] [Related]
10. PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level.
Banerji CRS; Zammit PS
Hum Mol Genet; 2019 Jul; 28(13):2224-2236. PubMed ID: 31067297
[TBL] [Abstract][Full Text] [Related]
11. Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation.
Collins CA; Gnocchi VF; White RB; Boldrin L; Perez-Ruiz A; Relaix F; Morgan JE; Zammit PS
PLoS One; 2009; 4(2):e4475. PubMed ID: 19221588
[TBL] [Abstract][Full Text] [Related]
12. Emerin inhibits Lmo7 binding to the Pax3 and MyoD promoters and expression of myoblast proliferation genes.
Dedeic Z; Cetera M; Cohen TV; Holaska JM
J Cell Sci; 2011 May; 124(Pt 10):1691-702. PubMed ID: 21525034
[TBL] [Abstract][Full Text] [Related]
13. Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHD-related repeats.
Bosnakovski D; Daughters RS; Xu Z; Slack JM; Kyba M
PLoS One; 2009 Sep; 4(9):e7003. PubMed ID: 19756142
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs.
Soleimani VD; Punch VG; Kawabe Y; Jones AE; Palidwor GA; Porter CJ; Cross JW; Carvajal JJ; Kockx CE; van IJcken WF; Perkins TJ; Rigby PW; Grosveld F; Rudnicki MA
Dev Cell; 2012 Jun; 22(6):1208-20. PubMed ID: 22609161
[TBL] [Abstract][Full Text] [Related]
15. Gene expression during normal and FSHD myogenesis.
Tsumagari K; Chang SC; Lacey M; Baribault C; Chittur SV; Sowden J; Tawil R; Crawford GE; Ehrlich M
BMC Med Genomics; 2011 Sep; 4():67. PubMed ID: 21951698
[TBL] [Abstract][Full Text] [Related]
16. Zac1/GPR39 phosphorylating CaMK-II contributes to the distinct roles of Pax3 and Pax7 in myogenic progression.
Yang Q; Li Y; Zhang X; Chen D
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):407-419. PubMed ID: 29079520
[TBL] [Abstract][Full Text] [Related]
17. Comparative expression analysis of Pax3 and Pax7 during mouse myogenesis.
Horst D; Ustanina S; Sergi C; Mikuz G; Juergens H; Braun T; Vorobyov E
Int J Dev Biol; 2006; 50(1):47-54. PubMed ID: 16323077
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesoderm.
Magli A; Baik J; Mills LJ; Kwak IY; Dillon BS; Mondragon Gonzalez R; Stafford DA; Swanson SA; Stewart R; Thomson JA; Garry DJ; Dynlacht BD; Perlingeiro RCR
PLoS Biol; 2019 Feb; 17(2):e3000153. PubMed ID: 30807574
[TBL] [Abstract][Full Text] [Related]
19. Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.
Charytonowicz E; Matushansky I; Castillo-Martin M; Hricik T; Cordon-Cardo C; Ziman M
Clin Transl Oncol; 2011 Mar; 13(3):194-203. PubMed ID: 21421465
[TBL] [Abstract][Full Text] [Related]
20. PAX3
Yang Q; Yu J; Yu B; Huang Z; Zhang K; Wu D; He J; Mao X; Zheng P; Chen D
Muscle Nerve; 2016 Nov; 54(5):943-951. PubMed ID: 27014961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
